The results of our study suggest no associations between the risk of multiple myeloma and MIP-1α, VEGF, and TGF-α serum levels in samples obtained 20 years (median) before the diagnosis of multiple myeloma. This evidence concerns the gene CCL3 and plasma cell myeloma.